Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

Overview of attention for article published in Journal of Clinical Oncology, March 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 6 news outlets
policy: 1 policy source

f1000: 1 research highlight platform

Readers on

mendeley: 136 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1 policy document that references this research output.

Non-Hodgkin’s lymphoma: diagnosis and management : Appendix G: Evidence review

Cited by National Institute for Health and Care Excellence (NICE) on 18 Jul 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.